共 124 条
[1]
Barthel FM(2009)How do multi-stage, multi-arm trials compare to the traditional two-arm parallel group design--a reanalysis of 4 trials Trials 10 1-10
[2]
Parmar MK(2006)Adjuvant goserelin in pre-menopausal patients with early breast cancer: Results from the ZIPP study Eur J Cancer 42 895-904
[3]
Royston P(2006)Futility approaches to interim monitoring by data monitoring committees Clin Trials 3 522-529
[4]
Baum M(2010)A general inefficacy interim monitoring rule for randomized clinical trials Clin Trials 7 197-208
[5]
Hackshaw A(2011)Long-term benefits of 5 years of tamoxifen: 10 year follow up of a large randomised trial in women aged at least 50 years with early breast cancer J Clin Oncol 29 1657-1663
[6]
Houghton J(1982)An aid to data monitoring in long-term clinical trials Control Clin Trials 3 311-323
[7]
Rutqvist T(2009)Informing the selection of futility stopping thresholds: case study from a late-phase clinical trial Pharm Stat 8 25-37
[8]
Fornander B(2009)Futility interim monitoring with control of type I and II error probabilities using the interim Z-value or confidence limit Clin Trials 6 565-573
[9]
Nordenskjold A(1983)Discrete sequential boundaries for clinical trials Biometrika 70 659-663
[10]
Nicolucci R(1982)Stochastically curtailed tests in long-term clinical trials Commun Stat C1 207-219